Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06340074 · ClinicalTrials.gov registry record · NA
Helping Educational Leadership Mobilize Evidence
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 333
- Enrollment target
NCT06340074 is a NA study that has completed, run by University of Washington. The registered enrollment target is 333 participants.
The verdict
NCT06340074, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 333 participants
- Enrollment target
Study Summary
Many universal, evidence-based prevention practices (EBPPs) have been developed to prevent SEB problems, typically in elementary schools, but progress toward widespread implementation has been slow and few efforts have been made to develop and test interventions to enhance EBPP implementation in schools. Schools leaders (e.g., principals) are key to decision making and implementation of EBPPs, and their leadership has been shown to be consistently linked to student outcomes through their intentional efforts to support teacher adoption and use of innovative programs. Helping Educational Leaders Mobilize (HELM) Evidence is a pragmatic, multifaceted, organizationally-focused implementation strategy targeting the implementation leadership and implementation climate of school buildings (through principals) to enhance the adoption and delivery of EBPPs in elementary schools. This pilot study, part of the larger HELM project to adapt and test the strategy based on an existing leadership intervention, Leadership and Organizational Change for Implementation (LOCI), will be implemented in the context of Positive Greetings at the Door (PGD), a universal school-based EBPP previously demonstrated to reduce disruptive behavior and increase academic engagement.
Interventions
- BEHAVIORAL HELM
- BEHAVIORAL Implementation Attention Control (IAC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2022-08-28 |
| Est. Completion | 2023-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06340074
The ClinicalTrials.gov registry entry for NCT06340074 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HELM is the first listed.
NCT06340074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06340074 about?
NCT06340074 is a clinical study titled "Helping Educational Leadership Mobilize Evidence". Many universal, evidence-based prevention practices (EBPPs) have been developed to prevent SEB problems, typically in elementary schools, but progress toward widespread implementation has been slow and few efforts have been made to develop and test interventions to enhance EBPP implementation in sch...
What is the current status of trial NCT06340074?
This trial is currently completed. It is a NA study. The enrollment target is 333 participants. The study started on 2022-08-28. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT06340074?
The interventions under investigation include: HELM (BEHAVIORAL), Implementation Attention Control (IAC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06340074?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.